Alkermes plc (NASDAQ: ALKS) is 11.13% higher on its value in year-to-date trading and has touched a low of $22.90 and a high of $32.88 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ALKS stock was last observed hovering at around $31.23 in the last trading session, with the day’s gains setting it 0.73%.
Currently trading at $31.96, the stock is 3.52% and 5.89% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.48 million and changing 2.34% at the moment leaves the stock 17.16% off its SMA200. ALKS registered 19.39% gain for a year compared to 6-month gain of 22.59%. The firm has a 50-day simple moving average (SMA 50) of $30.1278 and a 200-day simple moving average (SMA200) of $27.2427.
The stock witnessed a 13.82% loss in the last 1 month and extending the period to 3 months gives it a 10.32%, and is 2.11% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.09% over the week and 2.59% over the month.
Alkermes plc (ALKS) has around 2100 employees, a market worth around $5.17B and $1.51B in sales. Current P/E ratio is 16.28 and Fwd P/E is 18.28. Profit margin for the company is 22.15%. Distance from 52-week low is 39.56% and -2.80% from its 52-week high. The company has generated returns on investments over the last 12 months (20.22%).
with sales reaching $379.42M over the same period.The EPS is expected to grow by 82.03% this year, but quarterly earnings will post -9.45% year-over-year. Quarterly sales are estimated to grow 0.51% in year-over-year returns.
Alkermes plc (ALKS) Top Institutional Holders
472.0 institutions hold shares in Alkermes plc (ALKS), with institutional investors hold 114.48% of the company’s shares. The shares outstanding are 161.78M, and float is at 158.39M with Short Float at 7.18%. Institutions hold 112.55% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 29.11 million shares valued at $701.49 million. The investor’s holdings represent 17.3276% of the ALKS Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 20.0 million shares valued at $$482.0 million to account for 11.9058 of the shares outstanding. The other top investors are WELLINGTON MANAGEMENT GROUP LLP which holds 14.35 million shares representing 8.5453% and valued at over $345.95 million, while PRICE T ROWE ASSOCIATES INC /MD/ holds 6.5556 of the shares totaling 11.01 million with a market value of $265.4 million.
Alkermes plc (ALKS) Insider Activity
The most recent transaction is an insider sale by Hopkinson Craig C.,the company’sEVP R&D, Chief Medical Officer. SEC filings show that Hopkinson Craig C. sold 100,918 shares of the company’s common stock on Jan 30 ’25 at a price of $32.05 per share for a total of $3.23 million. Following the sale, the insider now owns 44290.0 shares.
Still, SEC filings show that on Dec 09 ’24, Hopkinson Craig C. (EVP R&D, Chief Medical Officer) disposed off 61,151 shares at an average price of $32.07 for $1.96 million. The insider now directly holds 47,576 shares of Alkermes plc (ALKS).
